Advertisement
Screener

VANDA PHARMACEUTICALS INC. (VNDA) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

VANDA PHARMACEUTICALS INC. Basic Shares Outstanding (Weighted Average)

VANDA PHARMACEUTICALS INC. (VNDA) reported Basic Shares Outstanding (Weighted Average) of 60.23 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06

  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 60.23M shares, a 2.09% increase year-over-year.
  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 59.46M shares, a 1.59% increase year-over-year.
  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 59.10M shares, a 1.36% increase year-over-year.
  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 59.09M shares, a 1.42% increase year-over-year.
  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 58.93M shares, a 1.34% increase from fiscal 2024.
  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 58.15M shares, a 1.34% increase from fiscal 2023.
  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 57.38M shares, a 1.63% increase from fiscal 2022.
  • VANDA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 56.46M shares, a 1.64% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 12 month
2026-06-3060.23M shares
10-Q · filed 2026-08-06
59.85M shares
10-Q · filed 2026-08-06
59.60M shares
derived: average of 3 quarters · filed 2026-08-06
59.47M shares
derived: average of 4 quarters · filed 2026-08-06
2026-03-3159.46M shares
10-Q · filed 2026-05-07
59.28M shares
derived: average of 2 quarters · filed 2026-05-07
59.22M shares
derived: average of 3 quarters · filed 2026-05-07
59.16M shares
derived: average of 4 quarters · filed 2026-08-06
2025-12-3159.10M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
59.10M shares
derived: average of 2 quarters · filed 2026-02-12
59.06M shares
derived: average of 3 quarters · filed 2026-08-06
58.93M shares
10-K · filed 2026-02-12
2025-09-3059.09M shares
10-Q · filed 2025-10-30
59.04M shares
derived: average of 2 quarters · filed 2026-08-06
58.87M shares
10-Q · filed 2025-10-30
58.73M shares
derived: average of 4 quarters · filed 2026-08-06
2025-06-3058.99M shares
10-Q · filed 2026-08-06
58.76M shares
10-Q · filed 2026-08-06
58.61M shares
derived: average of 3 quarters · filed 2026-08-06
58.52M shares
derived: average of 4 quarters · filed 2026-08-06
2025-03-3158.53M shares
10-Q · filed 2026-05-07
58.42M shares
derived: average of 2 quarters · filed 2026-05-07
58.37M shares
derived: average of 3 quarters · filed 2026-05-07
58.33M shares
derived: average of 4 quarters · filed 2026-05-07
2024-12-3158.31M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
58.29M shares
derived: average of 2 quarters · filed 2026-02-12
58.26M shares
derived: average of 3 quarters · filed 2026-02-12
58.15M shares
10-K · filed 2026-02-12
2024-09-3058.26M shares
10-Q · filed 2025-10-30
58.24M shares
derived: average of 2 quarters · filed 2025-10-30
58.10M shares
10-Q · filed 2025-10-30
57.94M shares
derived: average of 4 quarters · filed 2026-02-12
2024-06-3058.22M shares
10-Q · filed 2025-07-31
57.99M shares
10-Q · filed 2025-07-31
57.84M shares
derived: average of 3 quarters · filed 2026-02-12
57.76M shares
derived: average of 4 quarters · filed 2026-02-12
2024-03-3157.76M shares
10-Q · filed 2025-05-08
57.65M shares
derived: average of 2 quarters · filed 2026-02-12
57.60M shares
derived: average of 3 quarters · filed 2026-02-12
57.57M shares
derived: average of 4 quarters · filed 2026-02-12
2023-12-3157.53M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
57.53M shares
derived: average of 2 quarters · filed 2026-02-12
57.50M shares
derived: average of 3 quarters · filed 2026-02-12
57.38M shares
10-K · filed 2026-02-12
2023-09-3057.52M shares
10-Q · filed 2024-11-07
57.49M shares
derived: average of 2 quarters · filed 2024-11-07
57.33M shares
10-Q · filed 2024-11-07
57.16M shares
derived: average of 4 quarters · filed 2025-02-14
2023-06-3057.45M shares
10-Q · filed 2024-08-01
57.23M shares
10-Q · filed 2024-08-01
57.04M shares
derived: average of 3 quarters · filed 2025-02-14
56.92M shares
derived: average of 4 quarters · filed 2025-02-14
2023-03-3157.01M shares
10-Q · filed 2024-05-09
56.83M shares
derived: average of 2 quarters · filed 2025-02-14
56.75M shares
derived: average of 3 quarters · filed 2025-02-14
56.69M shares
derived: average of 4 quarters · filed 2025-02-14
2022-12-3156.65M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14
56.61M shares
derived: average of 2 quarters · filed 2025-02-14
56.58M shares
derived: average of 3 quarters · filed 2025-02-14
56.46M shares
10-K · filed 2025-02-14
2022-09-3056.57M shares
10-Q · filed 2023-11-09
56.54M shares
derived: average of 2 quarters · filed 2023-11-09
56.40M shares
10-Q · filed 2023-11-09
56.24M shares
derived: average of 4 quarters · filed 2024-02-08
2022-06-3056.51M shares
10-Q · filed 2023-07-28
56.31M shares
10-Q · filed 2023-07-28
56.13M shares
derived: average of 3 quarters · filed 2024-02-08
56.02M shares
derived: average of 4 quarters · filed 2024-02-08
2022-03-3156.11M shares
10-Q · filed 2023-05-03
55.95M shares
derived: average of 2 quarters · filed 2024-02-08
55.85M shares
derived: average of 3 quarters · filed 2024-02-08
55.79M shares
derived: average of 4 quarters · filed 2024-02-08
2021-12-3155.79M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
55.73M shares
derived: average of 2 quarters · filed 2024-02-08
55.68M shares
derived: average of 3 quarters · filed 2024-02-08
55.55M shares
10-K · filed 2024-02-08
2021-09-3055.67M shares
10-Q · filed 2022-11-03
55.63M shares
derived: average of 2 quarters · filed 2022-11-03
55.47M shares
10-Q · filed 2022-11-03
55.28M shares
derived: average of 4 quarters · filed 2023-02-09
2021-06-3055.58M shares
10-Q · filed 2022-08-04
55.37M shares
10-Q · filed 2022-08-04
55.15M shares
derived: average of 3 quarters · filed 2023-02-09
55.03M shares
derived: average of 4 quarters · filed 2023-02-09
2021-03-3155.15M shares
10-Q · filed 2022-05-06
54.94M shares
derived: average of 2 quarters · filed 2023-02-09
54.85M shares
derived: average of 3 quarters · filed 2023-02-09
54.76M shares
derived: average of 4 quarters · filed 2023-02-09
2020-12-3154.73M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09
54.70M shares
derived: average of 2 quarters · filed 2023-02-09
54.63M shares
derived: average of 3 quarters · filed 2023-02-09
54.43M shares
10-K · filed 2023-02-09
2020-09-3054.67M shares
10-Q · filed 2021-11-04
54.58M shares
derived: average of 2 quarters · filed 2021-11-04
54.33M shares
10-Q · filed 2021-11-04
54.09M shares
derived: average of 4 quarters · filed 2022-02-24
2020-06-3054.50M shares
10-Q · filed 2021-07-29
54.15M shares
10-Q · filed 2021-07-29
53.90M shares
derived: average of 3 quarters · filed 2022-02-24
53.75M shares
derived: average of 4 quarters · filed 2022-02-24
2020-03-3153.81M shares
10-Q · filed 2021-05-06
53.60M shares
derived: average of 2 quarters · filed 2022-02-24
53.50M shares
derived: average of 3 quarters · filed 2022-02-24
53.40M shares
derived: average of 4 quarters · filed 2022-02-24
2019-12-3153.39M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
53.34M shares
derived: average of 2 quarters · filed 2022-02-24
53.26M shares
derived: average of 3 quarters · filed 2022-02-24
53.14M shares
10-K · filed 2022-02-24
2019-09-3053.30M shares
10-Q · filed 2020-10-29
53.20M shares
derived: average of 2 quarters · filed 2020-10-29
53.05M shares
10-Q · filed 2020-10-29
52.91M shares
derived: average of 4 quarters · filed 2021-02-11
2019-06-3053.10M shares
10-Q · filed 2020-08-06
52.93M shares
10-Q · filed 2020-08-06
52.78M shares
derived: average of 3 quarters · filed 2021-02-11
52.68M shares
derived: average of 4 quarters · filed 2021-02-11
2019-03-3152.75M shares
10-Q · filed 2020-05-07
52.61M shares
derived: average of 2 quarters · filed 2021-02-11
52.54M shares
derived: average of 3 quarters · filed 2021-02-11
52.45M shares
derived: average of 4 quarters · filed 2021-02-11
2018-12-3152.47M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11
52.43M shares
derived: average of 2 quarters · filed 2021-02-11
52.35M shares
derived: average of 3 quarters · filed 2021-02-11
50.86M shares
10-K · filed 2021-02-11
2018-09-3052.39M shares
10-Q · filed 2019-11-07
52.28M shares
derived: average of 2 quarters · filed 2019-11-07
50.32M shares
10-Q · filed 2019-11-07
48.96M shares
derived: average of 4 quarters · filed 2020-02-26
2018-06-3052.17M shares
10-Q · filed 2019-08-01
49.27M shares
10-Q · filed 2019-08-01
47.81M shares
derived: average of 3 quarters · filed 2020-02-26
47.08M shares
derived: average of 4 quarters · filed 2020-02-26
2018-03-3146.34M shares
10-Q · filed 2019-05-03
45.63M shares
derived: average of 2 quarters · filed 2020-02-26
45.38M shares
derived: average of 3 quarters · filed 2020-02-26
45.22M shares
derived: average of 4 quarters · filed 2020-02-26
2017-12-3144.93M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
44.91M shares
derived: average of 2 quarters · filed 2020-02-26
44.85M shares
derived: average of 3 quarters · filed 2020-02-26
44.74M shares
10-K · filed 2020-02-26
2017-09-3044.89M shares
10-Q · filed 2018-11-07
44.80M shares
derived: average of 2 quarters · filed 2018-11-07
44.67M shares
10-Q · filed 2018-11-07
2017-06-3044.72M shares
10-Q · filed 2018-08-02
44.56M shares
10-Q · filed 2018-08-02
2017-03-3144.40M shares
10-Q · filed 2018-05-02
2016-12-3143.45M shares
10-K · filed 2019-02-19
2015-12-3142.25M shares
10-K · filed 2018-02-15
2014-12-3134.77M shares
10-K · filed 2017-02-17
2013-12-3133.32M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
32.32M shares
derived: average of 2 quarters · filed 2016-02-12
31.01M shares
derived: average of 3 quarters · filed 2016-02-12
30.35M shares
10-K · filed 2016-02-12
2013-09-3031.33M shares
10-Q · filed 2013-11-08
29.86M shares
derived: average of 2 quarters · filed 2013-11-08
29.36M shares
10-Q · filed 2013-11-08
29.07M shares
derived: average of 4 quarters · filed 2015-03-13
2013-06-3028.38M shares
10-Q · filed 2013-07-31
28.36M shares
10-Q · filed 2013-07-31
28.32M shares
derived: average of 3 quarters · filed 2015-03-13
28.30M shares
derived: average of 4 quarters · filed 2015-03-13
2013-03-3128.35M shares
10-Q · filed 2013-05-10
28.29M shares
derived: average of 2 quarters · filed 2015-03-13
28.27M shares
derived: average of 3 quarters · filed 2015-03-13
28.26M shares
derived: average of 4 quarters · filed 2015-03-13
2012-12-3128.23M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
28.23M shares
derived: average of 2 quarters · filed 2015-03-13
28.23M shares
derived: average of 3 quarters · filed 2015-03-13
28.23M shares
10-K · filed 2015-03-13
2012-09-3028.23M shares
10-Q · filed 2013-11-08
28.23M shares
derived: average of 2 quarters · filed 2013-11-08
28.23M shares
10-Q · filed 2013-11-08
28.20M shares
derived: average of 4 quarters · filed 2014-02-25
2012-06-3028.23M shares
10-Q · filed 2013-07-31
28.23M shares
10-Q · filed 2013-07-31
28.19M shares
derived: average of 3 quarters · filed 2014-02-25
28.17M shares
derived: average of 4 quarters · filed 2014-02-25
2012-03-3128.23M shares
10-Q · filed 2013-05-10
28.17M shares
derived: average of 2 quarters · filed 2014-02-25
28.15M shares
derived: average of 3 quarters · filed 2014-02-25
28.14M shares
derived: average of 4 quarters · filed 2014-02-25
2011-12-3128.11M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
28.11M shares
derived: average of 2 quarters · filed 2014-02-25
28.11M shares
derived: average of 3 quarters · filed 2014-02-25
28.11M shares
10-K · filed 2014-02-25
2011-09-3028.11M shares
10-Q · filed 2012-11-08
28.11M shares
derived: average of 2 quarters · filed 2012-11-08
28.10M shares
10-Q · filed 2012-11-08
28.09M shares
derived: average of 4 quarters · filed 2013-02-26
2011-06-3028.10M shares
10-Q · filed 2012-08-03
28.10M shares
10-Q · filed 2012-08-03
28.08M shares
derived: average of 3 quarters · filed 2013-02-26
28.06M shares
derived: average of 4 quarters · filed 2013-02-26
2011-03-3128.10M shares
10-Q · filed 2012-05-09
28.07M shares
derived: average of 2 quarters · filed 2013-02-26
28.05M shares
derived: average of 3 quarters · filed 2013-02-26
28.01M shares
derived: average of 4 quarters · filed 2013-02-26
2010-12-3128.05M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
28.03M shares
derived: average of 2 quarters · filed 2013-02-26
27.98M shares
derived: average of 3 quarters · filed 2013-02-26
27.92M shares
10-K · filed 2013-02-26
2010-09-3028.00M shares
10-Q · filed 2011-11-07
27.95M shares
derived: average of 2 quarters · filed 2011-11-07
27.87M shares
10-Q · filed 2011-11-07
2010-06-3027.90M shares
10-Q · filed 2011-08-05
27.80M shares
10-Q · filed 2011-08-05
2009-12-3127.02M shares
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Evommune, Inc. (EVMN)United States$0.320B-5.10
Upstream Bio, Inc. (UPB)United States$0.284B-2.42